Search research articles
Contact Us
Filters
Showing results (41-50 of 213) with videos related to
Page
of 22
Sort By:
The Journal of Urology
|
February 4, 2021
Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study
Thomas Amiel, Christoph Würnschimmel, Matthias Heck, et al.
Urologia Internationalis
|
September 13, 2021
Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated Patients
Mike Wenzel, Benedikt Hoeh, Konstatin Goeldner, et al.
The Journal of Urology
|
September 21, 2021
Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis
Luigi Nocera, Pierre I Karakiewicz, Mike Wenzel, et al.
European Urology Oncology
|
September 1, 2024
Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center Analysis
Mike Wenzel, Cristiana Cano Garcia, Clara Humke, et al.
Urologic Oncology
|
July 30, 2021
The impact of time to prostate specific antigen nadir on biochemical recurrence and mortality rates after radiation therapy for localized prostate cancer
Mike Wenzel, Charles Dariane, Fred Saad, et al.
World Journal of Urology
|
December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Mike Wenzel, Benedikt Hoeh, Clara Humke, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2025
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy
Mike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
European Urology Focus
|
July 13, 2019
Performance of Combined Magnetic Resonance Imaging/Ultrasound Fusion-guided and Systematic Biopsy of the Prostate in Biopsy-naïve Patients and Patients with Prior Biopsies
Felix Preisser, Lena Theissen, Mike Wenzel, et al.
European Urology Oncology
|
September 18, 2025
Re: Nicolas A. Soputro, Carter D. Mikesell, Salim K. Younis, et al. Propensity-matched Comparison of Single-port Transvesical Versus Standard Multiport Robotic Radical Prostatectomy. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.05.023
Fabrizio Di Maida, Carlo Andrea Bravi, Marcio Covas Moschovas, et al.
Frontiers in Surgery
|
October 18, 2019
MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?
Jessica Rührup, Felix Preisser, Lena Theißen, et al.
Page
of 22
Search research articles
Search
Showing results (41-50 of 213) with videos related to
Sort By:
Page
of 22
The Journal of Urology
|
February 4, 2021
Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study
Thomas Amiel, Christoph Würnschimmel, Matthias Heck, et al.
Urologia Internationalis
|
September 13, 2021
Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated Patients
Mike Wenzel, Benedikt Hoeh, Konstatin Goeldner, et al.
The Journal of Urology
|
September 21, 2021
Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis
Luigi Nocera, Pierre I Karakiewicz, Mike Wenzel, et al.
European Urology Oncology
|
September 1, 2024
Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center Analysis
Mike Wenzel, Cristiana Cano Garcia, Clara Humke, et al.
Urologic Oncology
|
July 30, 2021
The impact of time to prostate specific antigen nadir on biochemical recurrence and mortality rates after radiation therapy for localized prostate cancer
Mike Wenzel, Charles Dariane, Fred Saad, et al.
World Journal of Urology
|
December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Mike Wenzel, Benedikt Hoeh, Clara Humke, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2025
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy
Mike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
European Urology Focus
|
July 13, 2019
Performance of Combined Magnetic Resonance Imaging/Ultrasound Fusion-guided and Systematic Biopsy of the Prostate in Biopsy-naïve Patients and Patients with Prior Biopsies
Felix Preisser, Lena Theissen, Mike Wenzel, et al.
European Urology Oncology
|
September 18, 2025
Re: Nicolas A. Soputro, Carter D. Mikesell, Salim K. Younis, et al. Propensity-matched Comparison of Single-port Transvesical Versus Standard Multiport Robotic Radical Prostatectomy. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.05.023
Fabrizio Di Maida, Carlo Andrea Bravi, Marcio Covas Moschovas, et al.
Frontiers in Surgery
|
October 18, 2019
MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?
Jessica Rührup, Felix Preisser, Lena Theißen, et al.
Page
of 22